ロード中...
Assessment of current virotherapeutic application schemes: “hit hard and early” versus “killing softly”?
Over the past two decades, a considerable amount of oncolytic vector families has entered numerous clinical trials. However, to this date, the field has not yet been able to come to a common understanding regarding the best possible ways to administer oncolytic viruses to cancer patients. This is ma...
保存先:
| 出版年: | Mol Ther Oncolytics |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782955/ https://ncbi.nlm.nih.gov/pubmed/27119110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|